AstraZeneca PLC

Stock Chart, Company Information, and Scan Results

$193.31(as of Feb 6, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

AstraZeneca PLC Company Information, Fundamentals, and Technical Indicators

Stock Price$193.31
Ticker SymbolAZN
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees94,300
CountyUSA
Market Cap$584,177.9M
EBIDTA20,416.0M
10-Day Moving Average186.56
P/E Ratio64.12
20-Day Moving Average185.80
Forward P/E Ratio18.21
50-Day Moving Average184.00
Earnings per Share3.01
200-Day Moving Average158.17
Profit Margin16.67%
RSI58.42
Shares Outstanding3,100.6M
ATR6.66
52-Week High195.00
Volume3,117,256
52-Week Low120.99
Most Recent Support Level183.63
Book Value45,971.0M
Most Recent Resistance Level192.79
P/B Ratio13.11
Upper Keltner200.78
P/S Ratio10.37
Lower Keltner170.83
Debt-to-Equity Ratio200.78
Next Earnings DateUnknown
Cash Surplus-25,911.0M
Next Ex-Dividend DateUnknown

AstraZeneca is a Swedish-based pharmaceutical giant dedicated to discovering and developing innovative treatments for conditions like cancer and respiratory diseases. The company gained popularity during the novel COVID-19 pandemic with the development of viral vector vaccines to treat the virus. The company’s most popular product is Tagrisso—a medication used to treat lung carcinomas.

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.